The occurrence of malignant tumors, such as adenocarcinoma, is commonplace in the nasal region, characterized by a notably low incidence. This rarity often contributes to delayed diagnosis, rendering the condition challenging to manage. Here, we present the case of a 70-year-old man who presented with chronic left nasal obstruction, accompanied by headaches and recurrent epistaxis. The diagnostic investigation revealed an extensive and aggressive nasal adenocarcinoma, necessitating a hemi-maxillectomy for tumor excision. Subsequent reconstruction of the ipsilateral cheek was accomplished using a pectoralis major flap. Despite the initial intervention, the patient experienced a recurrence 1 year later. In sinonasal adenocarcinoma, nasal obstruction stands out as the predominant symptom, complemented by potential manifestations of swelling and facial deformation. The inherently aggressive nature of this tumor underscores the imperative for early diagnosis and meticulous management to achieve optimal therapeutic outcomes. The comprehensive approach involving surgical intervention and reconstruction reflects the complexity in treating advanced nasal adenocarcinomas.

1. Thompson LDR, Loney EL, Bishop JA, et al. Nasal, paranasal, and skull base tumours. In: WHO Classification of Tumours Editorial Board. Head and Neck Tumours. Ch. 2. Lyon, France: International Agency for Research on Cancer; 2022. [Last accessed on 2023 May 08].

2. Pradhan P, Panigrahi R, Misra P, Senapati U, Samantaray K. High-grade non-salivary non-intestinal adenocarcinoma of the nasal cavity - A less known entity. Int J Otorhinolaryngol Head Neck Surg. 2020;6(11):2163-2164.

3. Turner JH, Reh DD. Incidence and survival in patients with sinonasal cancer: A historical analysis of population-based data. Head Neck. 2012;34(6):877-885. doi: 10.1002/hed.21830

4. Heffner DK, Hyams VJ, Hauck KW, Lingeman C. Low-grade adenocarcinoma of the nasal cavity and paranasal sinuses. Cancer. 1982;50(2):312-322. doi: 10.1002/1097-0142(19820715)50:2<312:aid-cncr2820500225>3.0.co;2-z

5. Breda M, Miranda D, Pereira S, et al. Sinonasal adenocarcinoma - Hospital de Braga ENT department expertise. Port J Otorhinolaryngol Head Neck Surg. 2017;54(4):233-238.

6. Lund VJ, Stammberger H, Nicolai P, et al. European position paper on endoscopic management of tumours of the nose, paranasal sinuses and skull base. Rhinol Suppl. 2010;22:1- 143.

7. Madani I, Bonte K, Vakaet L, Boterberg T, De Neve W. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys. 2009;73(2):424-432. doi: 10.1016/j.ijrobp.2008.04.037

8. Bignami M, Lepera D, Volpi L, et al. Sinonasal non-intestinal-type adenocarcinoma: A retrospective review of 22 patients. World Neurosurg. 2018;120:e962-e969. doi: 10.1016/j.wneu.2018.08.201

9. Stelow EB, Mills SE, Jo VY, Carlson DL. Adenocarcinoma of the upper aerodigestive tract. Adv Anat Pathol. 2010;17(4):262-269. doi: 10.1097/PAP.0b013e3181e3bf80

10. Jain C, Caulley L, Macdonald KI, et al. Nasopharyngeal non-intestinal-type adenocarcinoma: A case report and updated review of the literature. Curr Oncol. 2017;24(1):e55-e60. doi: 10.3747/co.24.3299

11. Choussy O, Ferron C, Vedrine PO, et al. Adenocarcinoma of ethmoid: A GETTEC retrospective multicenter study of 418 cases. Laryngoscope. 2008;118(3):437-443. doi: 10.1097/MLG.0b013e31815b48e3

12. Verma V, Mendenhall WM, Werning JW. Polymorphous low-grade adenocarcinoma of the head and neck. Am J Clin Oncol. 2014;37(6):624-626. doi: 10.1097/COC.0b013e31827e5537

13. Neto AG, Pineda-Daboin K, Luna MA. Sinonasal tract seromucous adenocarcinomas: A report of 12 cases. Ann Diagn Pathol. 2004;7:154-159. doi: 10.1016/s1092-9134(03)00012-1

14. Kilic S, Samarrai R, Kilic SS, Mikhael M, Baredes S, Eloy JA. Incidence and survival of sinonasal adenocarcinoma by site and histologic subtype. Acta Otolaryngol. 2018;138(4):415-421. doi: 10.1080/00016489.2017.1401229